MBB Public Markets I LLC Takes $294,000 Position in Axon Enterprise, Inc $AXON

Key Points

• MBB Public Markets I LLC has purchased 559 shares of Axon Enterprise, valued at approximately $294,000, marking a new position for the institutional investor in the company.
• CEO Patrick W. Smith recently sold 10,000 shares of Axon stock for approximately $7.4 million, reducing his ownership by 0.33%.
• Equity analysts have set positive target prices for Axon Enterprise, with estimates ranging from $800.00 to $900.00 and a consensus rating of "Moderate Buy".

MBB Public Markets I LLC bought a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 559 shares of the biotechnology company's stock, valued at approximately $294,000.

Other hedge funds also recently bought and sold shares of the company. Fourth Dimension Wealth LLC acquired a new stake in Axon Enterprise in the fourth quarter worth $30,000. TCTC Holdings LLC increased its holdings in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its holdings in Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise during the 1st quarter worth about $32,000. Finally, Banque Transatlantique SA bought a new position in Axon Enterprise during the 1st quarter worth about $31,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

AXON stock traded up $5.02 during trading on Friday, reaching $756.13. 303,694 shares of the company were exchanged, compared to its average volume of 447,052. The company has a 50-day moving average of $761.10 and a two-hundred day moving average of $688.38. The company has a market capitalization of $59.36 billion, a price-to-earnings ratio of 186.70, a P/E/G ratio of 27.75 and a beta of 1.40. Axon Enterprise, Inc has a twelve month low of $375.71 and a twelve month high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm's quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Hadi Partovi purchased 1,358 shares of the firm's stock in a transaction on Wednesday, August 13th. The stock was purchased at an average cost of $740.00 per share, for a total transaction of $1,004,920.00. Following the transaction, the director owned 237,938 shares in the company, valued at $176,074,120. The trade was a 0.57% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 7,891 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the transaction, the insider owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. This trade represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,790 shares of company stock worth $34,304,947 over the last 90 days. 5.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Zacks Research lowered shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, September 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday, July 17th. UBS Group reaffirmed a "neutral" rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Bank of America boosted their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Finally, Needham & Company LLC set a $870.00 price objective on shares of Axon Enterprise and gave the company a "buy" rating in a report on Tuesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $837.69.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.